Biofrontera Inc. Form 8-K Summary
Business Context and Reporting Period
Biofrontera Inc. filed a Current Report on Form 8-K regarding a change in its independent registered public accounting firm. The report date and earliest event date were June 16, 2023. The new auditor was engaged for the fiscal year ending December 31, 2023.
Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating or financial metrics.
Material Changes
- On June 16, 2023, the Company engaged Marcum LLP as its new independent registered public accounting firm, with approval from the Audit Committee and Board of Directors.
- Grant Thornton LLP, the prior independent registered public accountant, resigned on May 30, 2023. That resignation was previously disclosed in a Form 8-K filed June 2, 2023.
- The filing states that neither the Company nor anyone acting on its behalf consulted with Marcum during the two fiscal years ended December 31, 2022 and 2021 or through June 16, 2023 regarding specified accounting, auditing, or financial reporting matters.
Guidance, Risks, and Unusual Items
The filing provides no financial guidance or business outlook. The Company states that Marcum provided no written report or oral advice that was a significant factor in the auditor-selection decision, and that there were no disagreements or reportable events involving Marcum as defined under Regulation S-K Item 304.
Key Facts to Verify
- Confirm the reasons for Grant Thornton’s May 30, 2023 resignation in the earlier Form 8-K.
- Review Marcum LLP’s subsequent audit reports and any disclosures regarding internal controls or accounting matters.
- Verify whether later filings identify disagreements, reportable events, or other developments related to the auditor transition.
- Note that the Form 8-K was signed June 20, 2023, although the reported event date was June 16, 2023.